TherapeuticsMD, Inc. (NYSE American: TXMD) today announced the launch of an underwritten public offering of 12.4 million shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE